Year | Panel |
Screening items# |
|||
---|---|---|---|---|---|
HPA | CH | CAH | G6PDd | ||
May | 100 | 80 | 100 | 100 | |
2015 | August | 100 | 80 | 100 | 100 |
October | 100 | 100 | 100 | 100 | |
May | 100 | 100 | 100 | 100 | |
2016 | August | 80 | 100 | 100 | 100 |
October | 100 | 100 | 100 | 100 | |
May | 100 | 100 | 100 | 100 | |
2017 | August | 100 | 100 | 100 | 100 |
October | 100 | 100 | 100 | 100 | |
May | 100 | 100 | 100 | 100 | |
2018 | August | 100 | 100 | 100 | 100 |
October | 100 | 100 | 100 | 100 | |
May | 100 | 100 | 100 | 100 | |
2019 | August | 100 | 100 | 100 | 100 |
October | 100 | 100 | 100 | 100 |
#100 points are given when all five replicates are classified correctly; 80 points or more is considered acceptable performance and less than 80 points is unacceptable.
HPA, hyperphenylalaninemia; CH, congenital hypothyroidism; CAH, congenital adrenocortical hyperplasia; G6PDd, glucose-6-phosphate dehydrogenase deficiency.